ImmunoVision

Executive Summary

ImmunoVision is a US-based specialty diagnostics company focused on immunoassay development and manufacturing, serving the autoimmune, infectious disease, and cancer diagnostics markets. As part of the Calbiotech family, the company leverages over three decades of experience (since 1985) in reagent supply and custom assay services. Its core capabilities include microtiter plate coating, protein purification, antibody labeling, and full assay development. ImmunoVision positions itself as a leader in autoimmune research, offering a comprehensive range of products and services to researchers and diagnostic labs. While the company operates in a competitive landscape, its long-standing expertise, integration within Calbiotech, and focus on niche autoimmune and oncology diagnostics provide a stable foundation for growth. With a growing demand for precision diagnostics, ImmunoVision is well-poised to expand its product portfolio and market reach.

Upcoming Catalysts (preview)

• Q3 2026Launch of new autoimmune diagnostic panel70% success
• Q4 2026Strategic partnership with oncology research institution60% success
• TBDExpansion of custom assay services to infectious disease biomarkers75% success